Is Serum Uric Acid to Creatinine Ratio Associated with Hypertension
                    and Metabolic Syndrome in Children with Obesity?

Emine Gulsah Ozdemir; Ayse Derya Bulus

doi:10.1055/a-2510-5233

Klin Padiatr
DOI: 10.1055/a-2510-5233

Original Article

Is Serum Uric Acid to Creatinine Ratio Associated with Hypertension and Metabolic Syndrome in Children with Obesity?

Ist das Verhältnis von Harnsäure zu Kreatinin im Serum mit Bluthochdruck und metabolischem Syndrom bei Kindern mit Fettleibigkeit verbunden?

Emine Gulsah Ozdemir

¹Department of Pediatric Nephrology, Ankara Ataturk Sanatorium Training and Research Hospital, Ankara, Turkey

,

Ayse Derya Bulus

²Department of Pediatric Endocrinology, Ankara Ataturk Sanatorium Training and Research Hospital, Ankara, Turkey

› Author Affiliations

Abstract

Background

Childhood obesity is a global health problem with increasing prevalence, leading to long-term cardiovascular complications. Research conducted on adults has established a correlation between serum uric acid to creatinine ratio (SUA/Cr) and metabolic syndrome (MetS) components. The study investigates the relationship between SUA/Cr and hypertension (HT) and MetS components in children with obesity.

Methods

A total of 103 children with obesity who underwent ambulatory blood pressure measurement (ABPM) were included the study and patients were divided into two groups “HT” (n=60) and “Normal” (n=43). Demographic, anthropometric, and laboratory characteristics were retrospectively analyzed.

Results

The study included 103 children (42 female, 61 male) with a mean age of 13.7±2.9 years. HT prevalence was significantly higher in patients with severe obesity and dyslipidemia (p=0.045, p=0.01). Males exhibited significantly higher SUA/Cr than females (p<0.001). However, SUA/Cr showed no significant differences between patients with and without HT, MetS, dyslipidemia, or hyperglycemia (p=0.69, p=0.64, p=0.90, p=0.37). Furthermore, linear regression analysis did not establish a significant effect of SUA/Cr on ABPM parameters (p>0.05).

Conclusion

In our cohort, no significant association was found between SUA/Cr and HT, as well as MetS components in children with obesity. These findings highlight the need for further investigation into the complex mechanisms regulating uric acid metabolism, obesity, and cardiovascular risk in children.

Zusammenfassung

Hintergrund

Fettleibigkeit bei Kindern ist ein weltweites Gesundheitsproblem mit zunehmender Prävalenz, das zu langfristigen kardiovaskulären Komplikationen führt. In Untersuchungen an Erwachsenen wurde ein Zusammenhang zwischen dem Verhältnis von Serumharnsäure zu Kreatinin (SUA/Cr) und Komponenten des metabolischen Syndroms (MetS) festgestellt. In dieser Studie wird der Zusammenhang zwischen SUA/Cr und Bluthochdruck (HT) und MetS-Komponenten bei Kindern mit Adipositas untersucht.

Methoden

Insgesamt 103 Kinder mit Adipositas, bei denen eine ambulante Blutdruckmessung (ABPM) durchgeführt wurde, wurden in die Studie aufgenommen, und die Patienten wurden in zwei Gruppen unterteilt: „HT“ (n=60) und „Normal“ (n=43). Demografische, anthropometrische und labortechnische Merkmale wurden retrospektiv analysiert.

Ergebnisse

Die Studie umfasste 103 Kinder (42 weiblich, 61 männlich) mit einem Durchschnittsalter von 13,7±2,9 Jahren. Die HT-Prävalenz war bei Patienten mit schwerer Adipositas und Dyslipidämie signifikant höher (p=0,045, p=0,01). Männer wiesen einen signifikant höheren SUA/Cr-Wert auf als Frauen (p<0,001). SUA/Cr zeigte jedoch keine signifikanten Unterschiede zwischen Patienten mit und ohne HT, MetS, Dyslipidämie oder Hyperglykämie (p=0,69, p=0,64, p=0,90, p=0,37). Außerdem ergab die lineare Regressionsanalyse keinen signifikanten Einfluss von SUA/Cr auf die ABPM-Parameter (p>0,05).

Schlussfolgerung

In unserer Kohorte wurde kein signifikanter Zusammenhang zwischen SUA/Cr und HT sowie den MetS-Komponenten bei Kindern mit Adipositas festgestellt. Diese Ergebnisse unterstreichen die Notwendigkeit einer weiteren Untersuchung der komplexen Mechanismen, die den Harnsäurestoffwechsel, die Adipositas und das kardiovaskuläre Risiko bei Kindern regulieren.

Keywords

serum uric acid to creatinine ratio - hypertension - metabolic syndrome - obesity - children

Schlüsselwörter

Verhältnis von Serumharnsäure zu Kreatinin - Bluthochdruck - Metabolisches Syndrom - Fettleibigkeit - Kinder

Full Text

References

References
1 Jha S, Mehendale AM. Increased Incidence of Obesity in Children and Adolescents Post-COVID-19 Pandemic: A Review Article. Cureus 2022; 14: e29348
2 Macumber I, Flynn JT. Obesity Hypertension: Clinical Aspects. In: Flynn JT, Ingelfinger JR, Brady TM, editors. Pediatric Hypertension. Cham: Springer International Publishing; 2023: 405-419
3 Manios Y, Karatzi K, Protogerou AD. et al. Prevalence of childhood hypertension and hypertension phenotypes by weight status and waist circumference: the Healthy Growth Study. Eur J Nutr 2018; 57: 1147-1155
4 Ogden CL, Carroll MD, Lawman HG. et al. Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988–1994 Through 2013–2014. JAMA 2016; 315: 2292-2299
5 Al-Hamad D, Raman V. Metabolic syndrome in children and adolescents. Transl Pediatr 2017; 6: 397-407
6 Thomazini F, de Carvalho BS, de Araujo PX. et al. High uric acid levels in overweight and obese children and their relationship with cardiometabolic risk factors: what is missing in this puzzle?. J Pediatr Endocrinol Metab 2021; 34: 1435-1441
7 Mangge H, Zelzer S, Puerstner P. et al. Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults. Obesity (Silver Spring) 2013; 21: E71-E77
8 Feig DI. Uric Acid in the Pathogenesis of Hypertension. In: Flynn JT, Ingelfinger JR, Brady TM, editors. Pediatric Hypertension. Cham: Springer International Publishing; 2023: 71-89
9 Liu N, Xu H, Sun Q. et al. The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors. Oxid Med Cell Longev 2021; 2021: 1470380
10 Ferrara LA, Wang H, Umans JG. et al. Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity. Nutr Metab Cardiovasc Dis 2014; 24: 1360-1364
11 Li L, Song Q, Yang X. Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults. J Diabetes Res 2019; 2019: 3175418
12 Al-Daghri NM, Al-Attas OS, Wani K. et al. Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients. Sci Rep 2017; 7: 12104
13 She D, Xu W, Liu J. et al. Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Patients with Overweight/Obesity. Diabetes Metab Syndr Obes 2023; 16: 3007-3017
14 Cao T, Tong C, Halengbieke A. et al. Serum uric acid to creatinine ratio and metabolic syndrome in middle-aged and elderly population: Based on the 2015 CHARLS. Nutr Metab Cardiovasc Dis 2023; 33: 1339-1348
15 Kawamoto R, Ninomiya D, Kikuchi A. et al. Serum uric acid to creatinine ratio is a useful predictor of renal dysfunction among diabetic persons. Diabetes Metab Syndr 2019; 13: 1851-1856
16 Hu J, Tang L, Zhan X. et al. Serum uric acid to creatinine ratio as a risk factor for mortality among patients on continuous ambulatory peritoneal dialysis: a multi-center retrospective study. Ren Fail 2023; 45: 2273979
17 Kawamoto R, Kikuchi A, Ninomiya D. et al. Serum uric acid to creatinine ratio is a useful predictor of all-cause mortality among hypertensive patients. Clin Hypertens 2023; 29: 10
18 National High Blood Pressure Education Program Working Group on High Blood Pressure in C, Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555-576
19 Lurbe E, Agabiti-Rosei E, Cruickshank JK. et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 2016; 34: 1887-1920
20 Flynn JT, Urbina EM, Brady TM. et al. Ambulatory Blood Pressure Monitoring in Children and Adolescents: 2022 Update: A Scientific Statement From the American Heart Association. Hypertension 2022; 79: e114-e124
21 Parati G, Stergiou G, OʼBrien E. et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 2014; 32: 1359-1366
22 Wuhl E, Witte K, Soergel M. et al. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002; 20: 1995-2007
23 Neyzi O, Bundak R, Gokcay G. et al. Reference Values for Weight, Height, Head Circumference, and Body Mass Index in Turkish Children. J Clin Res Pediatr Endocrinol 2015; 7: 280-293
24 Hampl SE, Hassink SG, Skinner AC. et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics. 2023 151.
25 Expert Panel on Integrated Guidelines for Cardiovascular H, Risk Reduction in C, Adolescents. et al. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128: S213-S256
26 Zimmet P, Alberti KG, Kaufman F. et al. The metabolic syndrome in children and adolescents – an IDF consensus report. Pediatr Diabetes 2007; 8: 299-306
27 Xing Y, Chen J, Liu J. et al. Relationship Between Serum Uric Acid-to-Creatinine Ratio and the Risk of Metabolic-Associated Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes 2022; 15: 257-267
28 Zhong D, Liu D, Guo Y. et al. Association of the serum uric acid to creatinine ratio with metabolic syndrome in the middle age and older population in China. Front Endocrinol (Lausanne) 2022; 13: 1060442
29 Wang R, Wu S, Wang J. et al. A nonlinear correlation between the serum uric acid to creatinine ratio and the prevalence of hypertension: a large cross-sectional population-based study. Ren Fail 2024; 46: 2296002
30 Casiglia E, Tikhonoff V, Virdis A. et al. Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values. J Hypertens 2023; 41: 180-186
31 Gu L, Huang L, Wu H. et al. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function. Diab Vasc Dis Res 2017; 14: 221-225
32 Liu J, Peng H, Wang C. et al. Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio. Int J Endocrinol 2023; 2023: 6928117
33 Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63: 3136-3141
34 Bolognesi A, Bortolotti M, Battelli MG. et al. Gender Influence on XOR Activities and Related Pathologies: A Narrative Review. Antioxidants (Basel). 2024 13.
35 Tao J, Shen X, Li J. et al. Serum uric acid to creatinine ratio and metabolic syndrome in postmenopausal Chinese women. Medicine (Baltimore) 2020; 99: e19959
36 Chen L, Zhu Z, Ye S. et al. The Serum Uric Acid to Serum Creatinine Ratio is an Independent Risk Factor for Diabetic Kidney Disease. Diabetes Metab Syndr Obes 2022; 15: 3693-3703
37 Ma C, Liu Y, He S. et al. C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid Levels. Front Endocrinol (Lausanne) 2020; 11: 600472
38 Dikker O, Aktas A, Sahin M. et al. The Association of Serum Uric Acid Levels and Various Uric Acid-Related Ratios with Insulin Resistance and Obesity: A Preliminary Study in Adolescents. Children (Basel). 2023 10.
39 Faul F, Erdfelder E, Lang AG. et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-191